1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of Tumours, revised 4th edition edn. International Agency for Research on Cancer, Lyon, France
2. Foucar K, Chabot-Richards D, Czuchlewski DR, Karner KH, Reichard KK, Vasef MA, Wilson CS, Zhang Q, Culbreath K (2018) Diagnostic pathology: blood and bone marrow, 2nd edn. Elsevier, Philadelphia
3. Reinig EF, Greipp PT, Chiu A, Howard MT, Reichard KK (2018) De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity. Mod Pathol 31(5):705–717. https://doi.org/10.1038/modpathol.2017.175
4. Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H (2016) Pure erythroid leukemia and erythroblastic sarcoma evolving from chronic myeloid neoplasms. Am J Clin Pathol 145(4):538–551. https://doi.org/10.1093/ajcp/aqw033
5. Dewald GW, Broderick DJ, Tom WW, Hagstrom JE, Pierre RV (1985) The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genet Cytogenet 18(1):1–10. https://doi.org/10.1016/0165-4608(85)90032-9